Journal of Biomedical and Sustainable Healthcare Applications


A Review of High Intensity Focused Ultrasound Focal Therapy Results Using the MRI Ultrasound Fusion



Journal of Biomedical and Sustainable Healthcare Applications

Received On : 12 May 2021

Revised On : 02 November 2021

Accepted On : 30 November 2021

Published On : 05 July 2022

Volume 02, Issue 02

Pages : 124-135


Abstract


To provide its therapeutic effects, High-Intensity Focused Ultrasound (HIFU) treatment makes use of ultrasonic waves that are transmitted through tissue medium. This non-invasive technology shows capacity for a variety of medical applications, including tumor ablation, vascular coagulation, and gene and drug delivery. Nonetheless, there are many problems that can arise from using this technology. The goal of this research was to examine the effectiveness of focused HIFU treatment for prostate cancer by employing an MRI-US fusion platform to pinpoint the precise location of the tumor and administer the therapy. Focal HIFU treatment for locally advanced prostate cancer is a prospective case series employed in this article. There must not be a Gleason 5 signal on the prostatic biopsy and the focal lesion must be less than 20 mm in size on multiparametric Magnetic Resonance Imaging (MRI) for inclusion. The first half of the series were treated with traditional HIFU focused treatment, whereas the second half were treated using an MRI-US fusion platform. Requirement for salvage treatment was used as the major outcome measure of treatment efficacy. Results of supplementary interest were Prostate Specific Antigen (PSA) change, intraoperative morbidity, postoperative clinical outcome, and tumor resurgence in follow-up biopsies.


Keywords


Ultrasound (US), High-Intensity Focused Ultrasound (HIFU), Magnetic Resonance Imaging (MRI), Focused Ultrasound Surgery (FUS)


  1. A. Wiggermann, M. Beldoch, F. Hoellen, and P. Hunold, “MR-guided high-intensity focused ultrasound treatment of uterine fibroids,” Res. Rep. Focus. Ultrasound, vol. 4, pp. 9–14, 2016.
  2. T. Tierney, W. Field, T. Selvakumar, and M. Hayes, “Treating patients with movement disorders using MRI-guided focused ultrasound: recent developments and challenges,” Res. Rep. Focus. Ultrasound, p. 5, 2015.
  3. S. Quinn, W. Chin, and J. Walbridge, “MR-guided focused ultrasound for the treatment of adenomyosis: current insights,” Res. Rep. Focus. Ultrasound, p. 1, 2015.
  4. K. Hertwig, “The ESPRIT project HIFI medical application,” in Designing User Interfaces for Hypermedia, Berlin, Heidelberg: Springer Berlin Heidelberg, 1995, pp. 225–235.
  5. S. Singh, K. K. M. Nair, J. S. Koruth, A. d’Avila, and A. Danon, “The role of high-intensity focused ultrasound in ablation of atrial fibrillation and other cardiac arrhythmias,” Res. Rep. Focus. Ultrasound, p. 11, 2015.
  6. A. Gul, S. Coban, A. R. Turkoglu, M. Guzelsoy, M. Ozturk, and N. A. Kankilic, “Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia-related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity,” Prostate Int., vol. 8, no. 4, pp. 152–157, 2020.
  7. M. Song, J.-Y. Chun, D. S. Yoo, J.-Y. Han, and M.-S. Choo, “Correlation of the overactive bladder symptom score, and the voiding diary and urodynamic parameters in patients with overactive bladder syndrome,” Low. Urin. Tract Symptoms, vol. 6, no. 3, pp. 180–184, 2014.
  8. P. M. Arlen et al., “Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time,” J. Urol., vol. 179, no. 6, pp. 2181–5; discussion 2185-6, 2008.
  9. S. Ahmed Memon, M. Adil, F. Raja Khan, S. Ullah, S. Rehmat, and N. Zad Gul, “Association between erectile dysfunction, cardiovascular risk factors, and coronary artery disease: Role of exercise stress testing and International Index of Erectile Function (IIEF-5) questionnaire,” Int. J. Cardiol. Heart Vasc., vol. 40, no. 101033, p. 101033, 2022.
  10. C. Wei et al., “The predictive value of conventional MRI combined with radiomics in the immediate ablation rate of HIFU treatment for uterine fibroids,” Int. J. Hyperthermia, vol. 39, no. 1, pp. 475–484, 2022.
  11. Y. T. Tsukiyama et al., “P1064The impact of P2Y12 reaction unit during percutaneous coronary intervention on intra-stent tissues and Peri-procedural myocardial injury in stable angina pectoris; From MECHANISM-elective study,” Eur. Heart J., vol. 38, no. suppl_1, 2017.
  12. G. Marra, P. Dell’oglio, M. Baghdadi, X. Cathelineau, R. Sanchez-Salas, and EvaluatioN of HIFU Hemiablation and short-term AndrogeN deprivation therapy Combination to Enhance prostate cancer control (ENHANCE) Study, “Multimodal treatment in focal therapy for localized prostate cancer using concomitant short-term androgen deprivation therapy: the ENHANCE prospective pilot study,” Minerva Urol. Nefrol., vol. 71, no. 5, pp. 544–548, 2019.
  13. I. G. Vetrano et al., “Contrast-enhanced ultrasound assisted surgery of intramedullary spinal cord tumors: Analysis of technical benefits and intra-operative microbubble distribution characteristics,” Ultrasound Med. Biol., vol. 47, no. 3, pp. 398–407, 2021.
  14. K. M. Rathbun and A. Zweig, “An affordable and easily recreated ultrasound phantom for deep vein thrombosis,” J. Vasc. Ultrasound, vol. 45, no. 2, pp. 64–66, 2021.
  15. A. PiñeiroCes, M. Bande Rodriguez, M. Rodriguez Blanco, L. Peña Madrid, M. J. Lopez Valladares, and M. J. Blanco Teijeiro, “Very high-frequency ultrasonography signs in bilateral acute choroidal effusion associated with systemic sulphonamide medications: 2 cases,” Case Rep. Ophthalmol., vol. 13, no. 1, pp. 64–69, 2022.
  16. D. Jacobson-Kram, “The effects of diagnostic ultrasound on sister chromatid exchange frequencies: a review of the recent literature,” J. Clin. Ultrasound, vol. 12, no. 1, pp. 5–10, 1984.
  17. M. Edla, M. Deguchi, and Y. Y. Lim, “A self-powered H-Bridge joule theory circuit for piezoelectric energy harvesting systems,” Power Electronic Devices and Components, vol. 3, no. 100015, p. 100015, 2022.
  18. K. V. Sharma et al., “Magnetic resonance imaging–guided high-intensity focused ultrasound applications in pediatrics: Early experience at children’s national medical center,” Top. Magn. Reson. Imaging, vol. 27, no. 1, pp. 45–51, 2018.
  19. S. Z. Bhan and S. V. A. V. Prasad, “Scope of improvement of design of major components for focused ultrasound equipment by employing the state-of-the-art active elements in coordination with artificial intelligence,” in Data Driven Approach Towards Disruptive Technologies, Singapore: Springer Singapore, 2021, pp. 573–582.
  20. M. W. Schoen et al., “Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases,” Prostate Cancer Prostatic Dis., 2022.
  21. M. A. Bakarev, V. P. Levin, I. V. Kachesov, and A. I. Neimark, “Morphological changes in tumor and nontumor tissue in the treatment of prostate adenocarcinoma with high-intensity focused ultrasound in combination with androgen deprivation,” Arkh. Patol., vol. 80, no. 3, pp. 26–33, 2018.
  22. M. Finotti, M. Romano, M. Brizzolari, M. Scopelliti, and G. Zanus, “Comment on: ‘A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis,’” Hepatobiliary Surg. Nutr., vol. 11, no. 4, pp. 640–642, 2022.
  23. C. G. Roehrborn, M. E. Spann, S. L. Myers, C. R. Serviss, L. Hu, and Y. Jin, “Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy,” Prostate Cancer Prostatic Dis., vol. 18, no. 1, pp. 43–48, 2015.
  24. N. Li, P. Yang, and J. Fang, “Transarterial chemoembolization (TACE) plus apatinib vs. TACE alone for hepatocellular carcinoma,” Clin. Res. Hepatol. Gastroenterol., vol. 46, no. 9, p. 102022, 2022.
  25. H. Rakova, “Efficiency of combination therapy of high focal ultrasounds HIFU with cold laser 635 nm on adipose tissue,” J. Obes. Weight Loss Ther., vol. 03, no. 02, 2013.
  26. S. Olaoluwa ONIGBINDE, C. Mopelola ASALEYE, A. Ayo SALAKO, B. Michael IDOWU, A. Olumayowa ONIGBINDE, and A. Laoye, “The effect of systemic hypertension on prostatic artery resistive indices in patients with benign prostate enlargement,” Prostate Int., 2022.
  27. M. Jacewicz, E. Rud, K. F. Galtung, D. Noor, and E. Baco, “Cancer detection rates in targeted transperineal MRI-TRUS elastic fusion-guided prostate biopsies performed under local anesthesia,” Anticancer Res., vol. 41, no. 9, pp. 4395–4400, 2021.
  28. G. I. Rudoy, “Analysis of the stability of nonlinear regression models to errors in measured data,” Pattern Recognit. Image Anal., vol. 26, no. 3, pp. 608–616, 2016.
  29. Experts from the RATICAL study (ALK testing in Chinese advanced non-small cell lung cancer patients: a national-wide multicenter prospective real world data study) and Molecular Pathology Committee of Chinese Society of Pathology, “Expert consensus on clinical practice of ALK fusion detection in non-small cell lung cancer in China,” Zhonghua Bing Li Xue Za Zhi, vol. 48, no. 12, pp. 913–920, 2019.
  30. S. Oh, J. Y. Ha, and Y. J. Cho, “Contrast-enhanced voiding ultrasonography to detect intrarenal reflux in children: comparison with 99mTc-DMSA renal scans,” Ultrasonography, vol. 41, no. 3, pp. 502–510, 2022.
  31. K. Tsukamoto, M. Nakahara, T. Nakahara, and M. Furue, “A young man with skin disorder and pancytopenia due to excessive oral methotrexate during treatment of rheumatoid arthritis,” Nishi Nihon hifuka, vol. 83, no. 4, pp. 317–320, 2021.
  32. O. Rouvière et al., “Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study,” Lancet Oncol., vol. 20, no. 1, pp. 100–109, 2019.
  33. B. P. Wu, D. Grits, V. Foorsov, J. Xu, P. Tankha, and R. B. Bolash, “Cooled and traditional thermal radiofrequency ablation of genicular nerves in patients with chronic knee pain: a comparative outcomes analysis,” Reg. Anesth. Pain Med., vol. 47, no. 11, pp. 685–690, 2022.
  34. A. Baba, R. Kurokawa, E. Rawie, M. Kurokawa, Y. Ota, and A. Srinivasan, “Normalized parameters of dynamic contrast-enhanced perfusion MRI and DWI-ADC for differentiation between posttreatment changes and recurrence in head and neck cancer,” AJNR Am. J. Neuroradiol., vol. 43, no. 8, pp. 1184–1189, 2022.
  35. J. Xu et al., “Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies,” Prostate Cancer Prostatic Dis., vol. 25, no. 3, pp. 422–430, 2022.

Acknowledgements


Author(s) thanks to Albert Einstein College of Medicine for this research support.


Funding


No funding was received to assist with the preparation of this manuscript.


Ethics declarations


Conflict of interest

The authors have no conflicts of interest to declare that are relevant to the content of this article.


Availability of data and materials


No data available for above study.


Author information


Contributions

All authors have equal contribution in the paper and all authors have read and agreed to the published version of the manuscript.


Corresponding author


Rights and permissions


Open Access This article is licensed under a Creative Commons Attribution NoDerivs is a more restrictive license. It allows you to redistribute the material commercially or non-commercially but the user cannot make any changes whatsoever to the original, i.e. no derivatives of the original work. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/


Cite this article


Becca Johnson, “A Review of High Intensity Focused Ultrasound Focal Therapy Results Using the MRI Ultrasound Fusion”, Journal of Biomedical and Sustainable Healthcare Applications, vol.2, no.2, pp. 124-135, July 2022. doi: 10.53759/0088/JBSHA202202014.


Copyright


© 2022 Becca Johnson. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.